Sight Sciences (SGHT) EVP Brenton Taylor receives 100,464 RSUs

Q: How is the 100,464 RSU grant to SGHT executive Brenton Taylor calculated?

The 100,464 RSUs equal a grant value of $650,000. The number of units was determined by dividing $650,000 by the closing price of Sight Sciences common stock on the February 3, 2026 grant date.

Q: What is the vesting schedule for Brenton Taylor’s 100,464 RSUs at Sight Sciences (SGHT)?

The 100,464 RSUs vest in 16 equal quarterly installments. Vesting starts on March 31, 2026 and continues through December 31, 2029, subject to Brenton Taylor’s continued service with Sight Sciences through each vesting date.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Sight Sciences executive Brenton Taylor reported a new equity award. As EVP, Operations & R&D, he received 100,464 restricted stock units (RSUs) on February 3, 2026 under the company’s 2021 Incentive Award Plan, recorded as an acquisition of common stock at a price of $0 per share.

The grant size is based on dividing $650,000 by the closing price of Sight Sciences common stock on the grant date. These RSUs vest in 16 equal quarterly installments from March 31, 2026 through December 31, 2029, contingent on his continued service. After this award, he beneficially owns 270,676 shares, including 26,606 shares of common stock and 244,070 shares that will be acquired upon future RSU vesting and settlement.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Taylor Brenton

Role EVP, Operations & R&D

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	100,464	$0.00	--

Holdings After Transaction: Common Stock — 270,676 shares (Direct)

Footnotes (1)

Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $650,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026. Includes (i) 26,606 shares of Common Stock, and (ii) 244,070 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

02/05/2026 - 04:47 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taylor Brenton

(Last)

(First)

(Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK

94025

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Operations & R&D

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/03/2026		A		100,464⁽¹⁾	A	$0	270,676⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $650,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026.

2. Includes (i) 26,606 shares of Common Stock, and (ii) 244,070 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

	/s/Jeremy Hayden, Attorney-in-Fact for Brenton Taylor	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Sight Sciences (SGHT) report for Brenton Taylor?

Brenton Taylor reported receiving 100,464 RSUs from Sight Sciences. The equity award was granted on February 3, 2026 under the 2021 Incentive Award Plan and is recorded as an acquisition of common stock at a price of $0 per share.

How is the 100,464 RSU grant to SGHT executive Brenton Taylor calculated?

The 100,464 RSUs equal a grant value of $650,000. The number of units was determined by dividing $650,000 by the closing price of Sight Sciences common stock on the February 3, 2026 grant date.

What is the vesting schedule for Brenton Taylor’s 100,464 RSUs at Sight Sciences (SGHT)?

The 100,464 RSUs vest in 16 equal quarterly installments. Vesting starts on March 31, 2026 and continues through December 31, 2029, subject to Brenton Taylor’s continued service with Sight Sciences through each vesting date.

How many Sight Sciences (SGHT) shares does Brenton Taylor beneficially own after this filing?

After the grant, Brenton Taylor beneficially owns 270,676 shares. This includes 26,606 shares of common stock and 244,070 additional shares that will be acquired upon the vesting and settlement of unvested restricted stock units.

What role does Brenton Taylor hold at Sight Sciences (SGHT) in this Form 4?

Brenton Taylor is listed as EVP, Operations & R&D at Sight Sciences. The Form 4 identifies him as an officer of the company, not a director or 10% owner, and reports his compensation-related RSU grant.

Are the RSUs granted to Sight Sciences (SGHT) executive Brenton Taylor immediately settled in shares?

No, the RSUs represent a contingent right to receive shares. Each RSU corresponds to one share of Sight Sciences common stock, which will be delivered only upon vesting and settlement over the defined quarterly schedule.